Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Ling Lin, Qing Song, Wei Cheng, Cong Liu, Yi-Yang Zhao, Jia-Xi Duan, Jing Li, Dan Liu, Xin Li, Yan Chen, Shan Cai & Ping Chen. (2022) Comparation of predictive value of CAT and change in CAT in the short term for future exacerbation of chronic obstructive pulmonary disease. Annals of Medicine 54:1, pages 875-885.
Read now
Read now
Pei-Ju Chen, Kuang-Yao Yang, Wann-Cherng Perng, Kuan-Chia Lin & Kwua-Yun Wang. (2018) Effect of dyspnea on frailty stages and related factors in Taiwanese men with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2463-2469.
Read now
Read now
Zijing Zhou, Aiyuan Zhou, Yiyang Zhao, Jiaxi Duan & Ping Chen. (2018) A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysis. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1675-1682.
Read now
Read now
Marc Miravitlles, Jesús Molina, José Antonio Quintano, Anna Campuzano, Joselín Pérez & Carlos Roncero. (2018) Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 823-831.
Read now
Read now
Anjan Nibber, Alison Chisholm, Juan José Soler-Cataluña, Bernardino Alcazar, David Price & Marc Miravitlles. (2017) Validating the Concept of COPD Control: A Real-world Cohort Study from the United Kingdom. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:5, pages 504-512.
Read now
Read now
Yusheng Cheng, Xiongwen Tu, Linlin Pan, Shuai Lu, Ming Xing, Linlin Li & Xingwu Chen. (2017) Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2069-2074.
Read now
Read now
David MG Halpin, Marc Miravitlles, Norbert Metzdorf & Bartolomé Celli. (2017) Impact and prevention of severe exacerbations of COPD: a review of the evidence. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2891-2908.
Read now
Read now
Shujing Chen, Changhui Wang, Bing Li, Guochao Shi, Huiping Li, Jing Zhang, Yutong Gu, Jian Zhou, Yuanlin Song & Chunxue Bai. (2017) Risk factors for FEV1 decline in mild COPD and high-risk populations. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 435-442.
Read now
Read now
Juan Luis García-Rivero, Cristina Esquinas, Miriam Barrecheguren, Marc Bonnin-Vilaplana, Patricia García-Sidro, Alberto Herrejón, Carlos Martinez-Rivera, Rosa Malo de Molina, Pedro Jorge Marcos, Sagrario Mayoralas, Elsa Naval, Jose Antonio Ros, Manuel Valle & Marc Miravitlles. (2017) Risk Factors of Poor Outcomes after Admission for a COPD Exacerbation: Multivariate Logistic Predictive Models. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:2, pages 164-169.
Read now
Read now
Articles from other publishers (14)
Hendrik Johannes Prins, Ruud Duijkers, Johannes M A Daniels, Thys van der Molen, Tjip S van der Werf & Wim Boersma. (2021) COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD. BMJ Open Respiratory Research 8:1, pages e000761.
Crossref
Crossref
Alexa Nuñez, Viviana Marras, Matevz Harlander, Evgeni Mekov, Matjaz Turel, Rossen Petkov, David Lestan, Nikolay Yanev, Silvia Negri, Miriam Barrecheguren, Pietro Pirina, Marc Miravitlles & Cristina Esquinas. (2020) Clinical and spirometric variables are better predictors of COPD exacerbations than routine blood biomarkers. Respiratory Medicine 171, pages 106091.
Crossref
Crossref
Zijing Zhou, Aiyuan Zhou, Yating Peng, Jiaxi Duan, Yuqin Zeng, Yiyang Zhao, Wei Cheng & Ping Chen. (2020) Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study. Respiration 99:7, pages 606-616.
Crossref
Crossref
Marc Miravitlles, Vladimir Koblizek, Cristina Esquinas, Branislava Milenkovic, Adam Barczyk, Ruzena Tkacova, Attila Somfay, Kirill Zykov, Neven Tudoric, Kosta Kostov, Zuzana Zbozinkova, Michal Svoboda, Jurij Sorli, Alvils Krams & Arschang Valipour. (2019) Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study. Respiratory Medicine 150, pages 141-148.
Crossref
Crossref
Richard H. StanfordMatthew S. LauYong LiStephen Stemkowski. (2019) External Validation of a COPD Risk Measure in a Commercial and Medicare Population: The COPD Treatment Ratio. Journal of Managed Care & Specialty Pharmacy 25:1, pages 58-69.
Crossref
Crossref
Adolfo Baloira, José Miguel Rodriguez Gonzalez-Moro, Estefanía Sanjuán, Juan Antonio Trigueros & Ricard Casamor. (2018) Degree of control of patients with chronic obstructive pulmonary disease in Spain: SINCON study. BMC Pulmonary Medicine 18:1.
Crossref
Crossref
Alex J. Mackay, Konstantinos Kostikas, Lindsey Murray, Fernando J. Martinez, Marc Miravitlles, Gavin Donaldson, Donald Banerji, Francesco Patalano & Jadwiga A. Wedzicha. (2018) Patient-reported Outcomes for the Detection, Quantification, and Evaluation of Chronic Obstructive Pulmonary Disease Exacerbations. American Journal of Respiratory and Critical Care Medicine 198:6, pages 730-738.
Crossref
Crossref
Yuanhang Zheng, Zeshui Xu, Yue He & Huchang Liao. (2018) Severity assessment of chronic obstructive pulmonary disease based on hesitant fuzzy linguistic COPRAS method. Applied Soft Computing 69, pages 60-71.
Crossref
Crossref
Vladimir Fijačko, Marina Labor, Mirjana Fijačko, Sanda Škrinjarić-Cincar, Slavica Labor, Iva Dumbović Dubravčić, Tatjana Bačun, Aleksandar Včev, Sanja Popović-Grle & Davor Plavec. (2018) Predictors of short-term LAMA ineffectiveness in treatment naïve patients with moderate to severe COPD. Wiener klinische Wochenschrift 130:7-8, pages 247-258.
Crossref
Crossref
Marc Miravitlles, Pawel Sliwinski, Chin Kook Rhee, Richard W. Costello, Victoria Carter, Jessica Tan, Therese Sophie Lapperre, Bernardino Alcazar, Caroline Gouder, Cristina Esquinas, Juan Luis García-Rivero, Anu Kemppinen, Augustine Tee, Miguel Roman-Rodríguez, Juan José Soler-Cataluña & David B. Price. (2018) Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD. Respiratory Medicine 136, pages 8-14.
Crossref
Crossref
Zijing Zhou, Aiyuan Zhou, Yiyang Zhao & Ping Chen. (2017) Evaluating the Clinical COPD Questionnaire: A systematic review. Respirology 22:2, pages 251-262.
Crossref
Crossref
James F. Donohue, Vaidyanathan Ganapathy, Vamsi Bollu, Michael D. Stensland & Lauren M. Nelson. (2017) Health Status of Patients with Moderate to Severe COPD after Treatment with Nebulized Arformoterol Tartrate or Placebo for 1 Year. Clinical Therapeutics 39:1, pages 66-74.
Crossref
Crossref
Bernardino Alcazar, Pilar de Lucas, Joan B. Soriano, Alonso Fernández-Nistal, Antonia Fuster, Jose Miguel Rodríguez González-Moro, Aurelio Arnedillo, Patricia García Sidro & María José Espinosa de los Monteros. (2016) The evaluation of a remote support program on quality of life and evolution of disease in COPD patients with frequent exacerbations. BMC Pulmonary Medicine 16:1.
Crossref
Crossref
Cemil Kavalci, Muhittin Serkan Yilmaz, Afsin Emre Kayipmaz, Bahattin Isık, Elif Celikel, Gulsum Kavalci, Fevzi Yilmaz, Miray Ozlem, Bedriye Muge Sonmez & Selman Celebi. (2016) Correlation of CAT Score With Peak Expiratory Flow in Acute Exacerbation of COPD Patients. Journal of the National Medical Association 108:3, pages 164-168.
Crossref
Crossref